262 related articles for article (PubMed ID: 23826776)
1. The role of the androgen receptor in triple-negative breast cancer.
Shah PD; Gucalp A; Traina TA
Womens Health (Lond); 2013 Jul; 9(4):351-60. PubMed ID: 23826776
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
3. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
4. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
[TBL] [Abstract][Full Text] [Related]
5. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
Sutton LM; Cao D; Sarode V; Molberg KH; Torgbe K; Haley B; Peng Y
Am J Clin Pathol; 2012 Oct; 138(4):511-6. PubMed ID: 23010705
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Barton VN; D'Amato NC; Gordon MA; Christenson JL; Elias A; Richer JK
Horm Cancer; 2015 Dec; 6(5-6):206-13. PubMed ID: 26201402
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.
Nahleh Z
Future Oncol; 2008 Feb; 4(1):15-21. PubMed ID: 18240997
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
[TBL] [Abstract][Full Text] [Related]
9. Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.
Kono M; Fujii T; Lim B; Karuturi MS; Tripathy D; Ueno NT
JAMA Oncol; 2017 Sep; 3(9):1266-1273. PubMed ID: 28301631
[TBL] [Abstract][Full Text] [Related]
10. Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer.
Chae BJ; Lee A; Bae JS; Song BJ; Jung SS
J Surg Oncol; 2011 Jun; 103(8):768-72. PubMed ID: 21240988
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
Jiang HS; Kuang XY; Sun WL; Xu Y; Zheng YZ; Liu YR; Lang GT; Qiao F; Hu X; Shao ZM
Oncotarget; 2016 Jul; 7(27):41285-41293. PubMed ID: 27285752
[TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.
You CP; Leung MH; Tsang WC; Khoo US; Tsoi H
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053220
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of androgen receptor in triple negative breast cancer.
Luo X; Shi YX; Li ZM; Jiang WQ
Chin J Cancer; 2010 Jun; 29(6):585-90. PubMed ID: 20507730
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
Choi JE; Kang SH; Lee SJ; Bae YK
Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
[TBL] [Abstract][Full Text] [Related]
15. The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.
Lakis S; Kotoula V; Eleftheraki AG; Batistatou A; Bobos M; Koletsa T; Timotheadou E; Chrisafi S; Pentheroudakis G; Koutras A; Zagouri F; Linardou H; Fountzilas G
Breast; 2014 Jun; 23(3):234-43. PubMed ID: 24703723
[TBL] [Abstract][Full Text] [Related]
16. The Androgen Receptor: Is It a Promising Target?
Gucalp A; Traina TA
Ann Surg Oncol; 2017 Oct; 24(10):2876-2880. PubMed ID: 28766215
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers.
Zuo T; Wilson P; Cicek AF; Harigopal M
Hum Pathol; 2018 Oct; 80():239-245. PubMed ID: 29902579
[TBL] [Abstract][Full Text] [Related]
18. Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Karlsson C; Karlsson MG
PLoS One; 2020; 15(5):e0232519. PubMed ID: 32374753
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
He J; Peng R; Yuan Z; Wang S; Peng J; Lin G; Jiang X; Qin T
Med Oncol; 2012 Jun; 29(2):406-10. PubMed ID: 21264529
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of androgen receptor detection in operable breast cancer.
Søiland H; Kørner H; Skaland I; Janssen EA; Gudlaugsson E; Varhaug JE; Baak JP; Søreide JA
J Surg Oncol; 2008 Dec; 98(7):551-8. PubMed ID: 18937259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
